Compare MTLS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTLS | OSUR |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.9M | 275.4M |
| IPO Year | 2014 | 2000 |
| Metric | MTLS | OSUR |
|---|---|---|
| Price | $6.63 | $4.33 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 162.2K | ★ 802.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $6.38 | $4.48 |
| Revenue Next Year | $6.45 | $7.76 |
| P/E Ratio | $61.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.78 | $2.08 |
| 52 Week High | $7.00 | $4.58 |
| Indicator | MTLS | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 61.94 |
| Support Level | $5.44 | $2.90 |
| Resistance Level | $6.89 | $4.33 |
| Average True Range (ATR) | 0.26 | 0.23 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 41.96 | 62.32 |
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.